Pancreatic Cancer Research

ResearcherWeill Cornell MedicineActive in the last 2 years

Nicole C. Panarelli

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-1121-267X; OpenAlex author ID A5028132645. Sources: OpenAlex.

Their work

Papers
4 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2012: 1 paper · 2013: none · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper · 2026: 2 papers

Papers 4

  1. Tie2 inhibition disrupts TMEM doorway function and reduces dissemination in pancreatic ductal adenocarcinoma. Co-author DOI 10.1186/s13046-026-03730-6↗
  2. Mena (ENAH) Promotes KRAS-Driven Tumor Growth and Metastatic Progression in Pancreatic Ductal Adenocarcinoma Co-author DOI 10.64898/2026.01.07.698161↗
  3. Intraoperative Margin Analysis Does Not Improve Outcomes in Treatment-Naive or Neoadjuvantly-Treated Patients With Pancreatic Ductal Adenocarcinoma. Last author DOI 10.1016/j.modpat.2025.100826↗
  4. MicroRNA expression aids the preoperative diagnosis of pancreatic ductal adenocarcinoma. Co-author DOI 10.1097/mpa.0b013e318243a905↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. John Christopher McAuliffe · 3 shared papers, 2025–2026 · strength 0.83
  2. Lina A. Ariyan · 2 shared papers, 2026 · strength 0.51
  3. Érika Pereira Zambalde · 2 shared papers, 2026 · strength 0.51
  4. Xing Li · 1 shared paper, 2025 · strength 0.33
  5. Ben Z. Stanger · 1 shared paper, 2026 · strength 0.24
  6. Rhonda K. Yantiss · 1 shared paper, 2012 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.